Pasar al contenido principal

HIF2 & NFE2L2, UNA APROXIMACION RACIONAL Y OTRA IMPARCIAL PARA EL TRATAMIENTO DEL CANCER

PID2019-106937RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PI3Kβ-regulated β-catenin mediates EZH2 removal from promoters controlling primed human ESC stemness and primitive streak gene expression

  • Yadav, Sudhanshu
  • Garrido, Antonio
  • Hernández, M. Carmen
  • Oliveros, Juan C.
  • Pérez-García, Vicente
  • Fraga, Mario F.
  • Carrera, Ana C.
The mechanism governing the transition of human embryonic stem cells (hESCs) toward differentiated cells is only partially understood. To explore this transition, the activity and expression of the ubiquitous phosphatidylinositol 3-kinase (PI3Kα and PI3Kβ) were modulated in primed hESCs. The study reports a pathway that dismantles the restraint imposed by the EZH2 polycomb repressor on an essential stemness gene, NODAL, and on transcription factors required to trigger primitive streak formation. The primitive streak is the site where gastrulation begins to give rise to the three embryonic cell layers from which all human tissues derive. The pathway involves a PI3Kβ non-catalytic action that controls nuclear/active RAC1 levels, activation of JNK (Jun N-terminal kinase) and nuclear β-catenin accumulation. β-Catenin deposition at promoters triggers release of the EZH2 repressor, permitting stemness maintenance (through control of NODAL) and correct differentiation by allowing primitive streak master gene expression. PI3Kβ epigenetic control of EZH2/β-catenin might be modulated to direct stem cell differentiation., This work was funded by the Spanish Ministry of Science, Innovation and Universities (SAF2016-79195-R and PID2019-106937RB-I00), by the Madrid Regional Government (S2017/BMD-3804), and by the Spanish Association Against Cancer (16035CARR). V.P.-G. was supported by the Spanish Ministry of Science and Innovation (RYC-2019-026956 and PID2020-114459RA-I00).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma

  • Sánchez-Ortega, M
  • Garrido, A
  • Cirauqui, C
  • Sanz-Gonzalez, L
  • Hernández, M. C.
  • González-García, Ana
  • Obregon, K
  • Ferrer, I
  • Paz-Ares, L
  • Carrera, Ana C.
Original data will be available at https://doi.org/10.17632/9cwkxznpp2.1 Supplementary data to this article can be found online at https://doi.org/10.1016/j.redox.2024.103305, Extensive efforts have been conducted in the search for new targetable drivers of lung squamous cell carcinoma (LUSC); to date, however, candidates remain mostly unsuccessful. One of the oncogenic pathways frequently found to be active in LUSC is NFE2L2 (NRF2 transcription factor), the levels of which are regulated by KEAP1. Mutations in NFE2L2 or KEAP1 trigger NRF2 activation, an essential protector against reactive oxygen species (ROS). We hypothesized that the frequency of NRF2 activation in LUSC (∼35 %) may reflect a sensitivity of LUSC to ROS. Results from this study reveal that whereas tumors containing active forms of NRF2 were protected, ROS induction in wild-type NFE2L2/KEAP1 LUSC cells triggered ferroptosis. The mechanism of ROS action in normal-NRF2 LUSC cells involved transient NRF2 activation, miR-126-3p/miR-126-5p upregulation, and reduction of p85β and SETD5 levels. SETD5 levels reduction triggered pentose pathway gene levels increase to toxic values. Simultaneous depletion of p85βPI3K and SETD5 triggered LUSC cell death, while p85βPI3K and SETD5 overexpression rescued survival of ROS-treated normal-NRF2 LUSC cells. This shows that the cascade involving NRF2 > miR-126-3p, miR-126-5p > p85βPI3K and SETD5 is responsible for ROS-induced cell death in normal-NRF2 LUSC. Transient ROS-induced cell death is shown in 3D spheroids, patient-derived organoids, and in xenografts of wild-type NFE2L2/KEAP1 LUSC cells, supporting the potential of acute local ROS induction as a therapeutic strategy for LUSC patients with normal-NRF2., This work was supported by the Ministry of Science and innovation (MCIN) (PID2019-106937RB-I00 PIA12019; PDC-2022-133912-I00) by the Madrid Regional Government (S2020/BMD-7321), by the European Community, European COST Action CA20121 (BenBedPhar), and by the Spanish Association Against Cancer (16035CARR). M.S.-O. was sup- ported by the MCIN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24

  • Sánchez-Ortega, Miriam
  • Garrido, Antonio
  • Sanz, Lorena
  • Torres-Pérez, Rafael
  • Hernandez, Carmen
  • Gutierrez-Uzquiza, Alvaro
  • Tsao, Ming Sound
  • Carrera, Ana C.
The online version contains supplementary material available at https://doi.org/10.1186/s12943-025-02401-y., Lung squamous cell cancer (LUSC) is associated with very poor survival due to the lack of specific treatments. A common genetic alteration in LUSC involves mutations in NFE2L2 (protein named NRF2) or its regulator, KEAP1, resulting in increased activity of the NRF2 transcription factor (TF). This study compares the requirement for active-NRF2 in LUSC cell lines. Although normal-NRF2 cells are more sensitive to oxidative stress, they do not require NRF2 for survival under non-stress conditions, in contrast, LUSC cells with active-NRF2 mutations depend on NRF2 for viability. NRF2 depletion in patient-derived organoid cultures with active-NRF2 as well as in xenografts with active-NRF2 triggers cell death. The focus of this study is to find genes that rescue cell death upon NRF2-depletion in active-NRF2 cells. A CRISPRa/dCas9 screening for gene targets capable of rescuing cell survival in these cells identified TRIM24 as a gene whose expression saves cell survival in NRF2-depleted active-NRF2 LUSC cells. Alongside oxidative stress, the lack of TRIM24 selectively contributed to the induction of cell death (apoptosis and ferroptosis) in active-NRF2 LUSC cells. Cells with a high NFE2L2/KEAP1 copy number ratio also undergo cell death. The increase in cell death observed upon TRIM24 depletion involves a reduction of TRIM24/PI3Kα complexes which destabilizes the PI3Kα catalytic subunit. Notably, overexpression of PI3Kα rescues cell survival in TRIM24-depleted active-NRF2 cells. These findings point to novel therapeutic approaches in LUSC., This work was supported by the Ministry of Science and Innovation (MCIN) (PID2019-106937RB PIA12019; PDC-2022-133912) by the Madrid Regional Government (S2020/BMD-7321), the European Community, European COST Action CA20121 (BenBedPhar), by the Spanish Association Against Cancer (16035CARR) and the Canadian Institutes of Health Research FDN-148395. M.S.-O. was supported by the MCIN., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24

  • Sánchez-Ortega, Miriam
  • Garrido, Antonio
  • Sanz, Lorena
  • Torres-Pérez, Rafael
  • Hernandez, Carmen
  • Tsao, Ming Sound
  • Carrera, Ana Clara
  • Gutiérrez Uzquiza, Álvaro
Lung squamous cell cancer (LUSC) is associated with very poor survival due to the lack of specific treatments. A common genetic alteration in LUSC involves mutations in (protein named NRF2) or its regulator, , resulting in increased activity of the NRF2 transcription factor (TF). This study compares the requirement for active-NRF2 in LUSC cell lines. Although normal-NRF2 cells are more sensitive to oxidative stress, they do not require NRF2 for survival under non-stress conditions, in contrast, LUSC cells with active-NRF2 mutations depend on NRF2 for viability. NRF2 depletion in patient-derived organoid cultures with active-NRF2 as well as in xenografts with active-NRF2 triggers cell death. The focus of this study is to find genes that rescue cell death upon NRF2-depletion in active-NRF2 cells. A CRISPRa/dCas9 screening for gene targets capable of rescuing cell survival in these cells identified as a gene whose expression saves cell survival in NRF2-depleted active-NRF2 LUSC cells. Alongside oxidative stress, the lack of TRIM24 selectively contributed to the induction of cell death (apoptosis and ferroptosis) in active-NRF2 LUSC cells. Cells with a high copy number ratio also undergo cell death. The increase in cell death observed upon TRIM24 depletion involves a reduction of TRIM24/PI3Kα complexes which destabilizes the PI3Kα catalytic subunit. Notably, overexpression of PI3Kα rescues cell survival in TRIM24-depleted active-NRF2 cells. These findings point to novel therapeutic approaches in LUSC.